LGVN logo

LGVN
Longeveron Inc - Ordinary Shares - Class A

12,912
Mkt Cap
$21.87M
Volume
171,343.00
52W High
$1.83
52W Low
$0.475
PE Ratio
-0.72
LGVN Fundamentals
Price
$0.94
Prev Close
$0.9764
Open
$1.01
50D MA
$0.8554
Beta
0.99
Avg. Volume
14.62M
EPS (Annual)
-$1.29
P/B
3.80
Rev/Employee
$31,552.63
$5.06
Loading...
Loading...
News
all
press releases
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells Biotechs Racing to...
PR Newswire·16d ago
News Placeholder
More News
News Placeholder
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. PR...
PR Newswire·1mo ago
News Placeholder
Longeveron (LGVN) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·1mo ago
News Placeholder
Longeveron Braces For Q4 Results Following Recent Funding Boost
Longeveron Inc. shares are trading higher Tuesday as investors pivot their focus toward the company's Q4 earnings report, due after the bell.read more...
Benzinga·1mo ago
News Placeholder
Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal
Longeveron shares are trading sharply higher Tuesday afternoon following the announcement of a private placement agreement worth up to $30 million.read more...
Benzinga·2mo ago
News Placeholder
Best Biotech Stocks To Keep An Eye On - March 10th
Vertex Pharmaceuticals, BioNTech, Danaher, Longeveron, Moderna, United Therapeutics, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·2mo ago
News Placeholder
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study
Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.
Stocktwits·2mo ago
<
...
1
>

Latest LGVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.